BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 2981181)

  • 1. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
    Gabbay RA; Lardy HA
    FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes.
    Elks ML; Jackson M; Manganiello VC; Vaughan M
    Am J Physiol; 1987 Mar; 252(3 Pt 1):C342-8. PubMed ID: 3030132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation.
    Dax EM; Partilla JS; Gregerman RI
    J Lipid Res; 1981 Aug; 22(6):934-43. PubMed ID: 6268727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase.
    Lönnroth P; Smith U
    Biochem Biophys Res Commun; 1986 Dec; 141(3):1157-61. PubMed ID: 2434081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of partially purified NSILA on adenylate cyclase, phosphodiesterase and 3',5'-cyclic AMP in fat cells.
    Hepp KD; Renner R; Langley J; Häring HU
    Mol Cell Endocrinol; 1975 Oct; 3(4):309-21. PubMed ID: 172393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
    Elks ML; Manganiello VC
    Endocrinology; 1985 May; 116(5):2119-21. PubMed ID: 2985373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
    Kather H; Scheurer A
    Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
    Litosch I; Hudson TH; Mills I; Li SY; Fain JN
    Mol Pharmacol; 1982 Jul; 22(1):109-15. PubMed ID: 6289066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
    Wallace AV; Heyworth CM; Houslay MD
    Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive but reversible depletion of ATP via adenylate cyclase in rat adipocytes.
    Chung FZ; Weber HW; Appleman MM
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1614-7. PubMed ID: 3856840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation.
    Smith CJ; Vasta V; Degerman E; Belfrage P; Manganiello VC
    J Biol Chem; 1991 Jul; 266(20):13385-90. PubMed ID: 1649189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-phenylisopropyladenosine stimulates in normal and inhibits in adrenalectomized rats the low KM cyclic AMP phosphodiesterase in the brain.
    de Mazancourt P; Giudicelli Y
    Brain Res; 1984 May; 300(2):211-7. PubMed ID: 6329432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin reversal of the antilipolytic action of insulin in rat adipocytes in the presence of forskolin does not involve cyclic AMP.
    Mills I; Fain JN
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1059-65. PubMed ID: 2992496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of basal and hormone-stimulated adenylate cyclase in adipocyte ghosts by the prostaglandin endoperoxide prostaglandin H2.
    Gorman RR; Hamberg M; Samuelsson B
    J Biol Chem; 1975 Aug; 250(16):6460-3. PubMed ID: 169245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal control of cyclic AMP turnover in isolated fat cells.
    Häring HU; Renner R; Hepp KD
    Mol Cell Endocrinol; 1976; 5(3-4):295-302. PubMed ID: 182581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.